Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Sep;1(3):181-8.

Adverse drug reaction reporting in New Zealand: implications for pharmacists

Monica Zolezzi, Nirasha Parsotam

Adverse drug reaction reporting in New Zealand: implications for pharmacists

Monica Zolezzi et al. Ther Clin Risk Manag. 2005 Sep.

Abstract

Adverse drug reactions (ADRs) are a significant cause of morbidity and mortality and contribute to the incidence of adverse events, resulting in increased healthcare costs. Healthcare providers need to understand their role and responsibility in the detection, management, documentation, and reporting of ADRs, all essential activities for optimizing patient safety. The purpose of this article is to summarize findings from important ADR literature reviews and describe the components, and extent of participation, of the national ADR reporting program available in New Zealand. A series of recommendations to increase the detection of ADRs is also described.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Sources of adverse drug reaction (ADR) reports in New Zealand, January–June 2004. Abbreviations: GPs, general practitioners; HCPs, healthcare professionals; Rx, pharmacists.
See this image and copyright information in PMC

References

    1. Andrew I, Baker S, Chalmers A. Implementing a system for tackling under-reporting of adverse drug reactions within a district general hospital. Int J Pharm Pract. 2001;001(9 Suppl):R71.
    1. [ASHP] American Society of Health-System Pharmacists. 1995. Guidelines on adverse drug reaction monitoring and reporting [online]. Accessed Nov 2004. URL: www.ashp.org/bestpractices/MedMis/MedMis_Gdl_ADR.pdf
    1. Bates DW. Drugs and adverse drug reactions. How worried should we be? [editorial] JAMA. 1998;279:1216–17. - PubMed
    1. Brewer T, Colditz GA. Postmarketing surveillance and adverse drug reactions: current perspectives and future needs. JAMA. 1999;28:824–9. - PubMed
    1. Briant R, Ali W, Lay-Yee R, et al. Representative case series from public hospital admissions 1998. I: drug and related therapeutic adverse events. NZ Med J. 2004. [online]. Accessed Sep 2004. URL: http://www.nzma.org.nz/journal/117-1188/747/256d96007f6b4e/$FILE/Improvi... - PubMed

LinkOut - more resources